Tracey Brown
Technik-/Wissenschafts-/F&E-Leiter bei TELIX PHARMACEUTICALS LIMITED
Aktive Positionen von Tracey Brown
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TELIX PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Corporate Officer/Principal | 01.02.2020 | - |
Karriereverlauf von Tracey Brown
Ehemalige bekannte Positionen von Tracey Brown
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THE SUSTAINABLE NUTRITION GROUP LTD | Technik-/Wissenschafts-/F&E-Leiter | 27.06.2013 | 31.10.2015 |
Corporate Officer/Principal | 21.10.2009 | 27.06.2013 | |
ANATARA LIFESCIENCES LTD | Corporate Officer/Principal | 01.09.2016 | - |
Audeo Oncology, Inc.
Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Audeo Oncology, Inc. used to provide cancer treatment services. It focused on utilizing its Hyaluronic Acid Chemotransport technology for cancer drugs and tumor cells to enhance drug activities. The company was founded on June 1, 2012 and was headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2012 | - |
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Tracey Brown
Monash University | Doctorate Degree |
RMIT University | Graduate Degree |
Statistik
International
Australien | 7 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANATARA LIFESCIENCES LTD | Health Technology |
Private Unternehmen | 4 |
---|---|
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Health Technology |
The Sustainable Nutrition Group Pty Ltd.
The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |
Audeo Oncology, Inc.
Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Audeo Oncology, Inc. used to provide cancer treatment services. It focused on utilizing its Hyaluronic Acid Chemotransport technology for cancer drugs and tumor cells to enhance drug activities. The company was founded on June 1, 2012 and was headquartered in San Francisco, CA. | Health Technology |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia. | Health Technology |
- Börse
- Insiders
- Tracey Brown
- Erfahrung